Yaniv is one of the founders of MABA – Mid Atlantic Bio Angels (bioangels.net) a life science angel investor group, where he also administers MABA’s internal investment pools, and MABA’s co-investment Sidecar Fund (https://sidecarfund.bioangels.net/), for non MABA member investors.

He is also Chief Executive Officer of Native State Therapeutics, an early state biotechnology company in the neurodegeneration field, and President of Blue Cactus Consulting (bluecactusconsulting.com) a business strategy consulting group.

Yaniv is originally a physicist, who made the transition into the business world about 30 years ago, at which point he took the helm of his first company.  He has senior merger, acquisition, capitalization, turnaround leadership experience with companies ranging from start-up to growth. He has held positions of CEO, COO, President, and General Manager at a number of companies, including a bio-informatics company, a surgical laser company, a manufacturing, and distribution company, a software and network integration company, and several others.

Yaniv has mentored numerous life science and technology start-ups through BiomedX (formerly, the Columbia-Coulter Translational Research Partnership), the Bench-to-Bedside Initiative jointly sponsored by Weill-Cornell Medical Center, and the E-Lab for Life Science Entrepreneurs sponsored in part by the New York City Economic Development Corporation.  

Until recently, he was a member of the Board of Trustees of the Institute for Life Science Entrepreneurship, is currently a member of the NJ EDA’s Technology Advisory Board, and a past Chairman of the NJ chapter of the Licensing Executives Society (LES).